header image

News

Octapharma Group and Fresenius Kabi enter into an Exclusive License, Development and Supply Agreement for a HESylated recombinant protein

29.10.2009

Octapharma Group and Fresenius Kabi enter into an Exclusive License, Development and Supply Agreement for a HESylated recombinant protein. Octapharma Group and Fresenius Kabi have signed a License, Development and Supply...